Susanna M. Saario
Department of Pharmaceutical Chemistry
University of Kuopio
Kuopio
Finland
Name/email consistency: high
- Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. Saario, S.M., Laitinen, J.T. Basic Clin. Pharmacol. Toxicol. (2007)
- Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol. Saario, S.M., Laitinen, J.T. Chem. Biodivers. (2007)
- Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. Saario, S.M., Poso, A., Juvonen, R.O., Järvinen, T., Salo-Ahen, O.M. J. Med. Chem. (2006)
- URB754 has no effect on the hydrolysis or signaling capacity of 2-AG in the rat brain. Saario, S.M., Palomäki, V., Lehtonen, M., Nevalainen, T., Järvinen, T., Laitinen, J.T. Chem. Biol. (2006)
- Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Saario, S.M., Salo, O.M., Nevalainen, T., Poso, A., Laitinen, J.T., Järvinen, T., Niemi, R. Chem. Biol. (2005)
- Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Saario, S.M., Savinainen, J.R., Laitinen, J.T., Järvinen, T., Niemi, R. Biochem. Pharmacol. (2004)